Japanese drug company increases stake in DHG

Japan’s Taisho Pharmaceutical Co Ltd has successfully purchased 9.2 million shares of DHG Pharmaceutical Joint Stock Company, representing a 7.06 per cent stake.

The acquisition has lifted Taisho’s ownership to 32 per cent, making it the second largest shareholder in DHG.

The largest shareholder is Viet Nam’s sovereign fund, the State Capital Investment Corporation (SCIC), which holds a 43.31 per cent stake.

Recently DHG announced that its foreign ownership limit has been increased to 100 per cent. Previously, foreign holdings in DHG stayed at 49 per cent, the maximum level overseas investors can collectively own in a Vietnamese pharmaceutical firm.

Other shareholders include Viet Nam-focused asset management firms VinaCapital and Dragon Capital, Templeton Frontier Markets Fund and Templeton Emerging Markets Small Cap Fund.

DHG, established in Can Tho City in 1974, is one of the leading companies in the pharmaceutical cosmetics industry and functional foods in Viet Nam.

bizhub

>   CAG: Board Resolution (21/08/2018)

>   SCI: Change in number of outstanding shares (21/08/2018)

>   HOT: Board approves the business performance in the first 06 months of 2018 (21/08/2018)

>   C32: Approving the transaction agreements with related institution (21/08/2018)

>   VHM: Resolution on collecting shareholders' opinion (21/08/2018)

>   TCO: Board approves the business performance in the first 06 months of 2018 (21/08/2018)

>   KTC: Board Resolution (21/08/2018)

>   TAG: Change in number of outstanding voting shares (21/08/2018)

>   NMK: Admission trading registration of additional shares (21/08/2018)

>   DHG: Taisho reports the result of public tender offer for DHG shares (21/08/2018)